Literature DB >> 2193098

Identification of cell surface receptors for the Act-2 cytokine.

M Napolitano1, K B Seamon, W J Leonard.   

Abstract

We have identified cell surface receptors for Act-2, a secreted protein expressed upon activation of T cells, B cells, and monocytes. Although 125I-Act-2 showed little, if any, specific binding to resting peripheral blood lymphocytes (PBL) receptors were readily detected on PHA/PMA-activated PBL and a variety of cell lines including MT-2, HL60, DMSO differentiated HL60, HeLa, and K562 cells. The equilibrium dissociation constant (Kd) is 3-12 nM for MT-2, K562, and PBL activated with PHA/PMA for 40-80 h. We have also identified a rabbit polyclonal antiserum that can block Act-2 binding to its receptors. The ability to detect specific Act-2 receptors and the development of a blocking antiserum should prove valuable in efforts to molecularly clone the Act-2 receptor and to dissect the biological actions of Act-2.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2193098      PMCID: PMC2188139          DOI: 10.1084/jem.172.1.285

Source DB:  PubMed          Journal:  J Exp Med        ISSN: 0022-1007            Impact factor:   14.307


  13 in total

1.  Mitogenic activation of human T cells induces two closely related genes which share structural similarities with a new family of secreted factors.

Authors:  P F Zipfel; J Balke; S G Irving; K Kelly; U Siebenlist
Journal:  J Immunol       Date:  1989-03-01       Impact factor: 5.422

2.  A family of small inducible proteins secreted by leukocytes are members of a new superfamily that includes leukocyte and fibroblast-derived inflammatory agents, growth factors, and indicators of various activation processes.

Authors:  K D Brown; S M Zurawski; T R Mosmann; G Zurawski
Journal:  J Immunol       Date:  1989-01-15       Impact factor: 5.422

3.  A novel polypeptide secreted by activated human T lymphocytes.

Authors:  M D Miller; S Hata; R De Waal Malefyt; M S Krangel
Journal:  J Immunol       Date:  1989-11-01       Impact factor: 5.422

4.  Identification, cloning, and characterization of an immune activation gene.

Authors:  M A Lipes; M Napolitano; K T Jeang; N T Chang; W J Leonard
Journal:  Proc Natl Acad Sci U S A       Date:  1988-12       Impact factor: 11.205

5.  A conserved AU sequence from the 3' untranslated region of GM-CSF mRNA mediates selective mRNA degradation.

Authors:  G Shaw; R Kamen
Journal:  Cell       Date:  1986-08-29       Impact factor: 41.582

6.  Ligand: a versatile computerized approach for characterization of ligand-binding systems.

Authors:  P J Munson; D Rodbard
Journal:  Anal Biochem       Date:  1980-09-01       Impact factor: 3.365

7.  Automated synthesis and use of N-chloroacetyl-modified peptides for the preparation of synthetic peptide polymers and peptide-protein immunogens.

Authors:  W Lindner; F A Robey
Journal:  Int J Pept Protein Res       Date:  1987-12

8.  Identification and characterization of an inhibitor of haemopoietic stem cell proliferation.

Authors:  G J Graham; E G Wright; R Hewick; S D Wolpe; N M Wilkie; D Donaldson; S Lorimore; I B Pragnell
Journal:  Nature       Date:  1990-03-29       Impact factor: 49.962

9.  Identification of a common nucleotide sequence in the 3'-untranslated region of mRNA molecules specifying inflammatory mediators.

Authors:  D Caput; B Beutler; K Hartog; R Thayer; S Brown-Shimer; A Cerami
Journal:  Proc Natl Acad Sci U S A       Date:  1986-03       Impact factor: 11.205

10.  The interleukin 2 receptor. Functional consequences of its bimolecular structure.

Authors:  H M Wang; K A Smith
Journal:  J Exp Med       Date:  1987-10-01       Impact factor: 14.307

View more
  3 in total

1.  The human cytokine I-309 is a monocyte chemoattractant.

Authors:  M D Miller; M S Krangel
Journal:  Proc Natl Acad Sci U S A       Date:  1992-04-01       Impact factor: 11.205

2.  Antibody-mediated neutralization of primary isolates of human immunodeficiency virus type 1 in peripheral blood mononuclear cells is not affected by the initial activation state of the cells.

Authors:  J Y Zhou; D C Montefiori
Journal:  J Virol       Date:  1997-03       Impact factor: 5.103

3.  Heparan sulfate proteoglycan on leukemic cells is primarily involved in integrin triggering and its mediated adhesion to endothelial cells.

Authors:  Y Tanaka; K Kimata; A Wake; S Mine; I Morimoto; N Yamakawa; H Habuchi; S Ashikari; H Yamamoto; K Sakurai; K Yoshida; S Suzuki; S Eto
Journal:  J Exp Med       Date:  1996-11-01       Impact factor: 14.307

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.